Compounded Medication – Prescription Only

This product is a compounded orally disintegrating tablet formulation containing oxytocin and dispensed only pursuant to a valid prescription issued by a licensed healthcare provider. Oxytocin is a peptide hormone naturally produced in the human body. In compounding practice, orally disintegrating peptide formulations may be prescribed when a provider determines that individualized formulation, dosage form, or excipient selection is clinically appropriate for a specific patient. This product is not available for self-selection and may only be dispensed following provider authorization.

Compounded medications are not approved by the U.S. Food and Drug Administration (FDA). The FDA does not evaluate compounded formulations for safety, effectiveness, or quality. Compounding is performed by a state-licensed pharmacy pursuant to a patient-specific prescription. This page provides general, non-therapeutic information for educational and compliance purposes only. It does not describe intended use, therapeutic benefit, behavioral effects, emotional effects, or expected clinical outcomes.

General Scientific Information (Non-Therapeutic)

Oxytocin is referenced in scientific literature for its molecular structure and role within neuroendocrine signaling pathways. Research has examined its biochemical characteristics and receptor interactions in laboratory and controlled research environments. Descriptions of molecular or biochemical properties are provided solely for general scientific context. No claims are made regarding safety, effectiveness, social behavior, mood, emotional bonding, or suitability for any particular condition.

Contraindications

Oxytocin ODT should not be used in individuals who have a known hypersensitivity or allergy to oxytocin or any component of the compounded formulation; have experienced prior adverse reactions to peptide-based formulations; or have conditions in which oxytocin administration is contraindicated as determined by the prescribing healthcare provider. Use in pregnant or breastfeeding individuals should occur only if a licensed healthcare provider determines that potential risks and benefits have been carefully evaluated.

Warnings and Precautions

Systemic absorption of oxytocin may occur. Caution is advised in individuals with cardiovascular disease, fluid or electrolyte imbalances, or endocrine disorders. Patients should inform their healthcare provider of all medical conditions, medications, and supplements prior to using this compounded formulation. Use only as prescribed by a licensed healthcare provider.

Potential Side Effects

Reported side effects associated with peptide-based formulations containing oxytocin may include headache, dizziness, nausea, flushing, fatigue, or transient changes in blood pressure or heart rate. Serious adverse reactions are uncommon but may occur. Patients should seek immediate medical attention if they experience signs of a severe allergic reaction or unexpected systemic symptoms.